Mylan launches Hertraz, first trastuzumab biosimilar, in India

Mylan named as Gilead exclusive branded medicines partner for India Mylan announced that its India-based subsidiary Mylan Pharmaceuticals Private Limited has been named Gilead Sciences exclusive branded medicines business partner for India.

http://ift.tt/1fo5JWh